The Construction of ceRNA Regulatory Network Unraveled Prognostic Biomarkers and Repositioned Drug Candidates for the Management of Pancreatic Ductal Adenocarcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study reveals circular RNA (circRNA) regulatory networks in pancreatic cancer (PDAC). Key genes like ADAM12 and MET were identified as potential biomarkers and drug targets for PDAC treatment.
Area Of Science
- Oncology
- Molecular Biology
- Bioinformatics
Background
- Pancreatic ductal adenocarcinoma (PDAC) presents significant challenges due to late diagnosis, poor survival, and frequent metastasis.
- The precise molecular mechanisms driving PDAC development remain incompletely understood.
- Circular RNAs (circRNAs) are emerging as critical regulators in cancer, but their role in PDAC requires further elucidation.
Purpose Of The Study
- To investigate the molecular regulatory signatures of circRNAs in PDAC progression.
- To identify potential diagnostic biomarkers and candidate drug molecules for PDAC through network-based analysis.
- To provide novel insights into the ceRNA network in PDAC.
Main Methods
- Acquired and analyzed mRNA, miRNA, and circRNA expression profiles from nine PDAC microarray datasets.
- Performed differential expression analysis to identify DEGs, DEmiRNAs, and DEcircRNAs.
- Constructed a competing endogenous RNA (ceRNA) regulatory network and conducted network-based integrative analysis, including hub gene identification and molecular docking for drug repositioning.
Main Results
- A PDAC-specific ceRNA network was constructed, involving 12 DEcircRNAs, 64 DEGs, and 6 miRNAs.
- Five hub genes (ADAM12, MET, QKI, SEC23A, ZEB2) were identified, showing significant correlation with PDAC survival.
- Hub gene-associated proteins were detected in plasma, serum, and oral epithelium, suggesting potential non-invasive biomarkers. Drug repositioning analysis identified vorinostat, meclocycline sulfosalicylate, and trichostatin A as potential therapeutic agents.
Conclusions
- The study elucidates circRNA-driven ceRNA networks crucial for PDAC progression.
- Identified novel biomarkers (hub genes) with potential for non-invasive diagnosis and therapeutic targeting.
- Repositioned drugs like vorinostat show promise for PDAC treatment, offering new avenues for prevention and therapy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...